XML 105 R92.htm IDEA: XBRL DOCUMENT v3.22.4
Income taxes - Additional Information (Detail) - USD ($)
$ in Millions
1 Months Ended 3 Months Ended 12 Months Ended
Mar. 27, 2020
Mar. 31, 2020
Dec. 31, 2017
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2018
Income Taxes Disclosure [Line Items]              
Income tax expense       $ 33.8 $ 60.1 $ 15.9  
Business interest income, adjusted taxable income 30.00%     30.00%      
Current income taxes expense (benefit)       $ 36.4 51.2 28.2  
Deferred income taxes expense (benefit)       (2.6) 8.9 (12.3)  
Deferred income tax benefit from change in enacted tax rate           (0.2)  
Deferred income taxes       63.5 46.2    
CARES act of 2020, Business interest income, adjusted taxable income 50.00%            
Cash tax benefit recognized   $ 1.0          
Unrecognized tax benefits impact on effective tax rate       3.5      
Increase (decrease) in unrecognized tax benefits       1.2      
Accrued interest and penalties during the period       0.2 0.7 0.8  
Accrued interest and penalties end of the period       0.1 0.9    
Contran              
Income Taxes Disclosure [Line Items]              
Income taxes payable current       5.8 1.5    
Income taxes payable noncurrent       $ 33.4 44.5    
European Subsidiaries | Chemicals | Transition Tax              
Income Taxes Disclosure [Line Items]              
Current income tax expense provisional pursuant to transition tax     $ 74.1        
Income tax liability payable period       8 years     8 years
Payable to affiliate       $ 44.5      
European Subsidiaries | Chemicals | Transition Tax | Contran              
Income Taxes Disclosure [Line Items]              
Income taxes payable current       11.1      
Income taxes payable noncurrent       33.4      
European Subsidiaries | Chemicals | Income Taxes Payables [Member] | Transition Tax | Contran              
Income Taxes Disclosure [Line Items]              
Current income tax expense payable in increments over remainder of eight year period       44.5      
Corporate Tax Purposes | Kronos | Germany | Chemicals              
Income Taxes Disclosure [Line Items]              
Net operating loss carryforwards       414.0      
Corporate Tax Purposes | Kronos | Belgium | Chemicals              
Income Taxes Disclosure [Line Items]              
Net operating loss carryforwards       13.0      
Direct Investment in Subsidiary | Kronos              
Income Taxes Disclosure [Line Items]              
Deferred income taxes expense (benefit)       1.2 $ (5.0) $ 2.4  
Deferred income taxes       55.0      
Direct Investment in Subsidiary | Kronos | Maximum [Member]              
Income Taxes Disclosure [Line Items]              
Deferred income taxes       $ 155.4